| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-08-02 | Viaskin® Peanut | peanut allergy | 3 | DBV Technologies (France) | Allergic diseases - Immunological diseases |
| 2017-08-01 | GS010- adeno-associated viral vector containing the human NADH dehydrogenase 4 gene | Leber’s hereditary optic neuropathy (LHON) | 3 | Gensight Biologics (France) | Ophtalmological diseases - Genetic diseases - Rare diseases |
| 2017-08-01 | ACE 083 | Charcot-Marie-Tooth Disease | 2 | Acceleron Pharma (USA - CA) | Rare diseases - Neurological diseases - Genetic diseases |
| 2017-07-31 | Pexa-Vec (pexastimogene devacirepvec) with Opdivo®(nivolumab) | advanced hepatocellular carcinoma | 1-2 | Transgene (France) | Cancer - Oncology |
| 2017-07-31 | obeticholic acid (OCA) in combination with statin therapy | NASH (non-alcoholic steatohepatitis) | 2 | Intercept Pharmaceuticals (USA - NY) | Liver diseases - Hepatic diseases |
| 2017-07-31 | obeticholic acid (OCA) | primary sclerosing cholangitis | 2 | Intercept Pharmaceuticals (USA - NY) | Autoimmune diseases - Liver diseases - Hepatic diseases |
| 2017-07-27 | BI 695501 (biosimilar version of adalimumab Humira®) | psoriasis | 3 | Boehringer Ingelheim (Germany) | Autoimmune diseases - Dermatological diseases |
| 2017-07-27 | Diamyd® and vitamin D | type 1 diabetes |
1 | Diamyd Medical (Sweden) | Autoimmune diseases - Metabolic diseases |
| 2017-07-27 | durvalumab (MEDI4736) and tremelimumab | non-small cell lung cancer (NSCLC) | 3 | AstraZeneca (UK) | Cancer - Oncology |
| 2017-07-27 | dusquetide (SGX942) | oral mucositis in head and neck cancer patients being treated with chemoradiation | 3 | Soligenix (USA - NJ) | Cancer - Oncology |
| 2017-07-26 | nadorameran - CV7201 (prophylactic mRNA-based vaccine encoding rabies virus glycoprotein) | rabies | 1 | Curevac (Germany) | Infectious diseases |
| 2017-07-26 | oregovomab in combination with Hiltonol® | ovarian cancer | 1-2 | OncoQuest (Canada) | Cancer - Oncology |
| 2017-07-26 | Actemra®/RoActemra® (tocilizumab) | giant cell arteritis | 3 | Roche (Switzerland) | Autoimmune diseases |
| 2017-07-25 | rigosertib | pediatric RASopathies (juvenile myelomonocytic leukemia, | Onconova Therapeutics (USA - PA) | Rare diseases - Genetic diseases | |
| 2017-07-25 | Tivicay® (dolutegravir) | HIV infection | 3 | ViiV Healthcare (UK - USA) | Infectious diseases |
| 2017-07-24 | engineered oncolytic vaccinia virus VVWR-TK-RR--Fcu1 | preclinical | Transgene (France) | Cancer - Oncology | |
| 2017-07-24 | idiopathic pulmonary fibrosis (IPF) | Boehringer Ingelheim (Germany) | Lung diseases - Respiratory diseases - Rare diseases | ||
| 2017-07-24 | PF-06439535 (biosimilar version of bevacizumab - Avastin®) | advanced non-squamous non-small cell lung cancer | 3 | Pfizer (USA - NY) | Cancer - Oncology |
| 2017-07-24 | TG6002 | preclinical | Transgene (France) | Cancer - Oncology | |
| 2017-07-21 | bimekizumab | moderate to severe chronic plaque psoriasis | 2b | UCB (Belgium) | Autoimmune diseases - Dermatological diseases |
